Clinical Trial Update: Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic profile and safety of Androxal in male subjects with impaired renal function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 1 | Status: COMPLETED